EPIscan screening and profiling services provides a rapidly growing menu of cell-based bromodomain and histone methyltransferase (HMT) assays. Based on the novel InCELL Hunter™ technology, these assays provide a direct measure of compound permeability and binding in a native, cellular environment. Optimize your compounds based on binding and intracellular potencies and make more informed decisions about the therapeutic potential your lead compounds.
Experience You Can Trust
With EPIscan screening and profiling services, you can avoid expensive and time consuming assay development. Our highly skilled and experienced service team is able to provide you high quality, reproducible data in a fraction of the time to help you meet all your project timelines and requirements.
